Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DTYMK | P23919 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 5/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.53 |
| ▸ | CASP6 | P55212 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29935450 | 1.00 | DTYMK (0.62) | DTYMKTSHRCYP3A4CSNK2A1CASP6 | |
| Potassium Ion SCHEMBL11048083 | 0.98 | DTYMK (0.60) | DTYMKTSHRCYP3A4CSNK2A1CASP6 | |
| SCHEMBL11048087 | 0.98 | DTYMK (0.60) | DTYMKTSHRCYP3A4CSNK2A1CASP6 | |
| SCHEMBL8446509 | 0.98 | DTYMK (0.60) | DTYMKTSHRCYP3A4CSNK2A1CASP6 | |
| Hydrochloric Acid SCHEMBL3730916 | 0.98 | DTYMK (0.60) | DTYMKTSHRCYP3A4CSNK2A1CASP6 | |
| SCHEMBL295645 | 0.89 | DTYMK (0.51) | DTYMKTSHRCYP3A4CSNK2A1MEN1 | |
| SCHEMBL28395903 | 0.87 | TSHR (0.62) | DTYMKTSHRCYP3A4POLBALDH1A1 | |
| SCHEMBL9215380 | 0.86 | POLB (0.59) | DTYMKTSHRCYP3A4MEN1POLB | |
| SCHEMBL406111 | 0.85 | TSHR (0.60) | DTYMKTSHRCYP3A4CSNK2A1CASP6 | |
| SCHEMBL1277039 | 0.85 | TSHR (0.60) | DTYMKTSHRCYP3A4POLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 926 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| CN-120192230-A | Method for treating nitrobenzoic acid mixture as byproduct of 3-methyl-2-nitrobenzoic acid | 南昌大学 | 2025-06-24 | — | — | CN | claimed |
| CN-119080334-A | Comprehensive utilization method of nitric acid containing organic matters | 山东友道化学有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-118344743-B | High-viscosity modified asphalt and preparation method thereof | 南京航空航天大学 | 2024-11-26 | — | — | CN | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| CN-118388359-A | Preparation method of ethyl 5-methyl-2-aminobenzoate | 江西大宇医药股份有限公司 | 2024-07-26 | — | — | CN | claimed |
| CN-118344743-A | High-viscosity modified asphalt and preparation method thereof | 南京航空航天大学 | 2024-07-16 | — | — | CN | claimed |
| CN-116836081-A | Ether epoxy toughening agent and preparation method and application thereof | 中国林业科学研究院林产化学工业研究所 | 2023-10-03 | — | — | CN | claimed |
| CN-112441926-B | Method for co-producing m-methylbenzoic acid nitride and m-phthalic acid | 山东友道化学有限公司 | 2022-10-14 | — | — | CN | claimed |
| CN-112441926-A | Method for co-producing m-methylbenzoic acid nitride and m-phthalic acid | 山东有言环保科技有限公司 | 2021-03-05 | — | — | CN | claimed |
| US-7311767-B2 | Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| EP-0902683-A1 | AGONISTS IN THE COSTIMULATION OF TcR/CD3-INDUCED T-LYMPHOCYTES | RADOPATH LIMITED (GB) | 1999-03-24 | — | — | EP | claimed |
| WO-1997034593-A1 | AGONISTS IN THE COSTIMULATION OF TcR/CD3-INDUCED T-LYMPHOCYTES | RADOPATH LIMITED (GB) | 1997-09-25 | — | — | WO | claimed |
| US-4005145-A | ISOMERIZATION OF A,B-UNSATURATED OXO COMPOUNDS TO B,G-ISOMER | HOFFMANN-LA ROCHE INC. (US) | 1977-01-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | DTYMK 3866/4885TSHR 2894/4885CYP3A4 797/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | DTYMK 627/4885TSHR 4082/4885CYP3A4 548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.